For the 2019 Emerging Research Grant cycle, Hearing Health Foundation supported research in the following areas:



Four grants were awarded for research that will increase our understanding of the causes, diagnosis, and treatment of CAPD, an umbrella term for a variety of disorders that affect the way the brain processes auditory information. All four of our CAPD grantees are General Grand Chapter Royal Arch Masons International award recipients. See all researchers who have received or are currently receiving funding from the Royal Arch Masons.

erg19 Hendrickson.jpg

+Kristi Hendrickson, Ph.D., CCC-SLP

University of Iowa
Neural correlates of semantic structure in children who are hard of hearing

Mild to severe hearing loss places children at risk for delays in language development. One aspect of language that is affected is vocabulary development; children who are hard of hearing tend to know less about word meanings than their typical hearing peers. This gap in vocabulary skills is crucial because vocabulary is one of the strongest predictors of academic achievement. Therefore, it is essential to examine factors that are both: 1) amenable to change through intervention, and 2) influence vocabulary knowledge, in order to help close the vocabulary gap. One such factor is semantic memory structure (i.e., how the brain groups concepts with common properties). In essence, semantic structure determines how individuals understand and interact with the social and physical world. Yet, very little is known about how children with hearing loss structure semantic information in the brain. This project addresses a critical need by characterizing semantic structure in the brains of children who are hard of hearing, and results will inform vocabulary interventions. Given the predictive validity of vocabulary knowledge for academic achievement, improving vocabulary understanding in children with hearing loss has the potential to impact all aspects of language (form, content, and use).

Long-term goal: To identify key factors that influence language outcomes in children who are hard of hearing.

Hendrickson received her doctorate in language and communicative disorders from San Diego State University/University of California, San Diego, and was a postdoctoral fellow in the department of psychological and brain sciences at the University of Iowa. She is an assistant professor in the department of communication sciences and disorders at the University of Iowa, where she directs the Psycholinguistics Lab.

erg19 Muthaiah.jpg

+ Vijaya Prakash Krishnan Muthaiah, Ph.D.

University at Buffalo, the State University of New York
Potential of inhibition of poly ADP-ribose polymerase as a therapeutic approach in blast-induced cochlear and brain injury

Many potential drugs in the preclinical phase for treating different types of noise-induced hearing loss (from blast and non-blast noise) revolve around targeting oxidative stress or interfering in the cell death cascade. Though noise-induced oxidative stress and cell death is well studied in the auditory periphery, the effects of noise exposure on the central auditory system remains understudied, especially in blast noise exposure where both auditory and non-auditory structures in the brain are affected. Impulsive noise (blast wave)-induced hearing loss is different from continuous noise exposure as it is more likely to be accompanied by accelerated cognitive deficits, depression, anxiety, dementia, and brain atrophy. It is well established that poly ADP-ribose polymerase (PARP) is a key mediator of cell death and it is overactivated by oxidative stress. Thus this project will explore the potential of PARP inhibition as a potential therapeutic approach for blast-induced cochlear and brain injury. The dampening of PARP overactivation by its inhibitor 3-aminobenzamide is expected to both mitigate blast noise-induced oxidative stress and to interfere with the cell death cascade, thereby reducing cell death in both the peripheral and central auditory system.

Long-term goal: To determine the mechanisms underlying both the peripheral and central aspects of blast-induced auditory neurodegeneration; and to identify and characterize potential therapeutic targets for manifestations of blast-induced traumatic brain injury, including hearing loss, cochlear synaptopathy, tinnitus, and associated deficits.

Muthaiah completed his postdoctoral training in auditory neuroscience at the University at Buffalo and Purdue University in Indiana after receiving his doctorate in molecular biology–anatomy from the University of Madras, India. He is an assistant professor in the department of rehabilitation sciences at the University at Buffalo.

erg19 Hao Luo_HHF.jpg

+ Hao Luo, M.D., Ph.D.

Wayne State University
Cochlear electrical stimulation–induced tinnitus suppression and related neural activity change in the rat inferior colliculus

Tinnitus is a prevalent public health problem that affects millions of people and imposes a significant economic burden on society. Cochlear electrical stimulation (CES) is one promising treatment for managing tinnitus. However, little is known about the underlying mechanisms of CES-induced tinnitus suppression. In addition, electrode insertion during surgery can cause acute tissue trauma and cell losses, initiating programmed cell death within the damaged tissue of the cochlea. Recently, we demonstrated that cochlear stimulation suppressed tinnitus-like behaviors in rats, which is accompanied with tinnitus-related neural activity changes. We therefore suggest that CES-induced tinnitus suppression would be more robust when hearing is protected from implant trauma by intra-cochlear application of AM-111, a novel enzyme inhibitor.

Long term goal: To find the underlying mechanism of CES-induced tinnitus suppression and the optimal strategy to improve clinical trials and tinnitus management.

Luo received a medical degree from Anhui Medical University, China, and a doctorate from the University of Science and Technology of China. After completing postdoctoral training at the Rotman Research Institute in Canada, he is now a research associate in the Tinnitus and Auditory Neuroscience Research Lab at Wayne State University in Detroit.

erg19 Riggs.jpg

+ William “Jason” Riggs, Au.D.

The Ohio State University
Electrophysiological characteristics in children with auditory neuropathy spectrum disorder

This project will focus on understanding different sites of lesion (impairment) in children with auditory neuropathy spectrum disorder (ANSD). ANSD is a unique form of hearing loss that is thought to occur in approximately 10 to 20 percent of all children with severe to profound sensorineural hearing loss and results in abnormal auditory perception. Neural encoding processes of the auditory nerve in children using electrophysiologic techniques (acoustically and electrically evoked) will be investigated in order to provide objective evidence of peripheral auditory function. Results can then be used to optimize and impact care from the very beginning of cochlear implant use in children with this impairment.

Long-term goal: To use objective techniques to further target and investigate physiologic properties of the auditory system, which can be used to better understand the underlying lesion/impairment; and to improve clinical cochlear implant mapping strategies for children with ANSD through the information gleaned from objective electrophysiologic testing.

Riggs received his doctorate of audiology from the Northeast Ohio Au.D. Consortium. He is a research scientist in the department of otolaryngology–head and neck surgery at The Ohio State University.


HHF awarded seven grants for the best overall hearing research proposals. These grants were funded by HHF’s Board of Directors and donors who designated their gifts to fund the most promising hearing research.

erg19 DAbdul-Aziz.png

+ Dunia Abdul-Aziz, M.D.

Massachusetts Eye and Ear, Harvard Medical School
Targeting epigenetics to restore hair cells

Most commonly, deafness is due to loss of cochlear sensory hair cells, which can occur because of genetic diseases, loud noise, certain drugs, or aging, and it can also result in the development of sometimes disabling ringing in the ear (tinnitus) and sound sensitivity (hyperacusis). Balance disorders similarly arise from loss of respective sensory hair cells in the inner ear vestibular organ. Treatments aimed at reversing hearing loss by stimulating the recovery of hair cells are greatly needed. The death of these hair cells in the ear is permanent because the inner ear loses its ability to replenish lost cells once it has matured, which occurs shortly after birth in mice and in the fetus in humans. To reestablish this potential and to recover lost hair cells, this project uses a novel technology to reprogram stem cells from the inner ear to turn into hair cells. This has pointed to a new candidate drug target, lysine-specific demethylase 1 (Lsd1), an epigenetic regulator that appears to be at least partly responsible for this loss of regenerative capacity. By targeting Lsd1, this project will study its role in the formation of hair cells and investigate its potential as a drug target for treatment of hearing loss.

Long-term goal: To develop novel therapies for hearing loss, balance disorders, tinnitus, and hyperacusis through the better understanding of hair cell development, maturation, and aging.

Abdul-Aziz received her medical degree from Harvard Medical School, jointly with the Massachusetts Institute of Technology. She is an instructor of otolaryngology at Harvard Medical School and a surgeon-scientist at Massachusetts Eye and Ear.

erg19 Pierre Apostolides.jpg

+ Pierre Apostolides, Ph.D.

University of Michigan
Novel mechanisms of cortical neuromodulation

Although there is currently no cure for tinnitus, recent experimental studies propose vagus nerve stimulation (VNS) may be a potential treatment to mitigate the condition because VNS releases natural chemicals (neuromodulators) that increase the brain’s ability to change. This is interesting because VNS has previously received Food and Drug Administration approval for treating drug-resistant epilepsy and treatment-resistant major depressive disorder. Despite considerable interest, how neuromodulators released by VNS could be therapeutically useful for tinnitus is unknown. This project will employ cutting-edge techniques to test a novel hypothesis: A major mechanism of action for neuromodulators is that they affect the function of dendrites, the long cable-like structures upon which neurons receive and integrate electrical signals. By identifying how neuromodulators impact the function of dendrites, these experiments may uncover novel targets for developing new treatments for tinnitus.

Long‐term goal: To achieve a mechanistic understanding of how neuromodulators control the excitability of dendrites in central auditory neurons; to identify how neuromodulators impact hearing and auditory perception; and to leverage this knowledge to guide the development of new treatments for hearing disorders.

Apostolides received his doctorate at the Vollum Institute, Oregon Health and Science University, and completed postdoctoral training at Janelia Research Campus, Howard Hughes Medical Institute, Virginia. He is an assistant professor at the University of Michigan’s Kresge Hearing Research Institute.

erg19 LawtonK.jpg

+ Kristy J. Lawton, Ph.D.

Washington State University Vancouver
Characterizing noise-induced synaptic loss in the zebrafish lateral line

Recent findings indicate that noise levels thought to be safe for auditory sensory hair cells may actually damage hearing at the level of peripheral auditory synapses. Little is known about this type of damage, which is usually not detectable using traditional audiograms and so has been dubbed “hidden hearing loss.” This project will study noise-induced hearing loss using zebrafish, where the auditory sensory cells are easily accessible and highly similar to those in humans, in order to uncover mechanisms of synaptic damage due to noise exposure. It will use a combination of techniques including immunohistochemistry and calcium imaging to directly examine the timing and extent of noise damage on peripheral auditory synapses.

Long-term goal: To identify mechanisms underlying noise-induced peripheral synaptic damage to inform the development of preventative measures and/or therapeutic options for noise-induced hearing loss.

Lawton received her doctorate in neurobiology and behavior from Cornell University, New York, and then completed postdoctoral research at Reed College, Oregon. She is currently a postdoctoral research associate in the integrative physiology and neuroscience department at Washington State University Vancouver.

erg19 Anat Lubetsky.jpg

+ Anat Lubetzky, Ph.D.

New York University
A balancing act in hearing and vestibular loss: assessing auditory contribution to multisensory integration for postural control in an immersive virtual environment

Humans are surrounded by sensory information and need to select the most reliable ones in order to maintain balance and disregard input that might make us fall. This is called “weighting” and “reweighting” of sensory inputs. This project uses a virtual reality, head-mounted display (HMD) application to test balance with varying sensory cues, including visual, somatosensory, and auditory. With this application, an individual’s ability to weight and reweight visual and auditory information based on their head and eye movement and their postural sway can be identified. This method has been successfully used in prior studies to test responses to visual changes. The novelty of this project includes: the addition of auditory cues scaled to well-established visual cues; the measurement of head movement via the HMD; and the portability, simplicity, and affordability of the HMD system, which increases the likelihood of future clinical translation of this assessment. In this current pilot study, 12 individuals with unilateral sensorineural hearing loss will be compared with 12 individuals with unilateral peripheral vestibular hypofunction and with 24 healthy controls. Wearing the HMD, they will go through a series of postural tasks with several combinations of visual and auditory cues of two intensity levels while standing on either a stable floor (all somatosensory cues available) or a compliant foam (to reduce somatosensory input). Their postural sway and head movement responses to the stimuli will be calculated, and gaze patterns among the groups will be compared, along with exploring whether changes in eye position can explain changes in head movement.

Long-term goal: To answer the following: whether a complete audiometric evaluation should be part of standard balance screening; should auditory cues be included in balance assessment and fall prevention programs; and whether rehabilitation of hearing loss improves balance. This line of research is significant for those with hearing loss because recently it has been suggested that balance impairment is an important, yet poorly recognized, implication of hearing loss and that individuals with hearing loss are at higher risk for falls.

Lubetzky received her doctorate in rehabilitation science from the University of Washington. She is an assistant professor in New York University’s physical therapy department.

erg19 Mattingly Jameson.jpg

+ Jameson Mattingly, M.D.

The Ohio State University
Differentiating Ménière's disease and vestibular migraine using audiometry and vestibular threshold measurements

Patients presenting with recurrent episodic vertigo (dizziness), such as Ménière's disease (MD) and vestibular migraine (VM), can present a diagnostic challenge as they can both produce recurrent vertigo, tinnitus, motion intolerance, and hearing loss. Further complicating this issue is that the diagnosis of each is based upon patient history with little contribution from an objective measure. Previous attempts to better differentiate MD and VM have included a variety of auditory and vestibular tests, but these evaluations have demonstrated limitations or not shown the appropriate sensitivity and specificity to be used in the clinical setting. Recently, vestibular perceptual threshold testing has shown the potential to better differentiate MD and VM by demonstrating different and opposite trends with testing, and these evaluations are ongoing. In addition to vestibular evaluations, audiometry (hearing testing) is a mainstay of testing in those with vestibular symptoms, especially with any concern of MD, and is thus commonly available. Standard hearing testing, however, is not sensitive or specific enough alone to differentiate MD and VM, but this project’s hypothesis is that combining audiograms with vestibular perceptual threshold testing will result in a diagnostic power greater than that possible with either option used individually. The population of patients with MD and VM is an ideal setting to examine similarities and differences, as MD is classically an otologic disease and VM, in theory, has little to do with auditory function. Additionally, this same principal can be applied to any disease process that affects both vestibular and auditory function (such as tumors, ototoxicity).

Long-term goal: To establish strong and reliable diagnostic tests to differentiate common etiologies of recurrent vestibulopathy, namely Ménière's disease and vestibular migraine; to further characterize the relationship between hearing and vestibular function within the context of these disease processes; and to examine both the vestibular and auditory systems and their relationships to each other.

Mattingly received his medical degree from the University of Louisville School of Medicine in Kentucky, completed a residency in otolaryngology at the University of Colorado Health Sciences Center, and an otology/neurotology fellowship at The Ohio State University, where he is joining its faculty. He will be working with co-principal investigator Daniel Merfeld, Ph.D.

erg19 SeigelHHFPhoto.JPG

+ Gail M. Seigel, Ph.D.

University at Buffalo, the State University of New York
Targeting microglial activation in hyperacusis

Hyperacusis is a hearing condition in which moderate-level noise becomes intolerable. The Centers for Disease Control estimates that nearly 6 percent of the U.S. population experiences some form of hyperacusis, ranging from mild discomfort to severe medical disability, with a diminished quality of life. There is currently no cure for hyperacusis. Therefore, there is a pressing medical need for targeted treatment approaches for the permanent relief of hyperacusis. This study will focus on the involvement of inflammation in the sound processing centers of the brain following noise exposure by using anti-inflammatory drugs to attempt to reduce inflammation and prevent hyperacusis after noise exposure. Results from this study will test the feasibility of anti-inflammatory drugs as a potential therapy for hyperacusis and hearing loss caused by excessive noise exposure.

Long-term goal: To prevent damaging inflammation in the brain caused by excessive noise exposure. Since hyperacusis is often associated with hearing loss, both conditions will benefit from the results of this study.

Seigel received her doctorate in microbiology/immunology at Albany Medical College in New York and is a research associate professor in the Center for Hearing and Deafness at the University at Buffalo.

erg19 Wong.jpeg

+ Victor Wong, Ph.D.

Burke Medical Research Institute, Weill Cornell Medicine
Targeting tubulin acetylation in spiral ganglion neurons for the treatment of hearing loss

Both the success of cochlear implants and of future therapeutic approaches critically depend on the integrity of spiral ganglion neurons and the availability of functional neurites (axons) for direct stimulation. Since very little is known about how to promote spiral ganglion neuron neurite growth, there is a critical need to understand how to reinforce these peripheral neurites to regenerate. Many of the molecular players that facilitate regeneration have been characterized in both the peripheral and central nervous systems. Among these are microtubules, which are a major mediator of the overall extension, consolidation, and navigation of the growing axon. In addition to providing structural support for the growth and targeting of axons, microtubules make up the major molecular “tracks” for transporting cargoes necessary for proper neurite function and growth. α-Tubulin, a major component of these tracks, can undergo a number of post-translational modifications which alter stability, intracellular transport, and axonal growth. α-Tubulin acetylation is an attractive target in particular since α-tubulin acetylation-promoting drugs have been found to increase neurite growth in injured neurons and to promote movement of intracellular cargoes such as mitochondria and mRNA. This project will examine how enhancing α-tubulin acetylation can alter the course of functional repair and regeneration of the molecular tracks after age-related and noise-induced hearing loss, thereby restoring auditory function.

Long-term goal: To establish the role of α-tubulin acetylation in regulating the neurite (axon) growth of spiral ganglion neurons under pathological conditions in order to develop new therapeutic approaches for individuals with hearing loss.

Wong received his doctorate in physiology from the University of Toronto and is a postdoctoral fellow in the Burke Neurological Institute at Weill Cornell Medicine in New York.


One grant was awarded for innovative research focused on congenital and acquired childhood hearing loss and its etiology, assessment, diagnosis and treatment. This grant was generously supported by The Children's Hearing Institute.

erg19 Easwar.jpg

+ Vijayalakshmi Easwar, Ph.D.

University of Wisconsin–Madison
Neural correlates of amplified speech in children with sensorineural hearing loss

About three of every 1,000 infants are born with permanent hearing loss. With the implementation of newborn hearing screening programs worldwide, infants born with hearing loss are now identified soon after birth and provided with hearing aids as early as 3 months of age. However, until infants are 8 to 10 months of age and can participate in clinical tests, the use of neural measures is the only feasible method to infer an infant’s hearing ability with hearing aids. This project will investigate the relationship between behavioral and neural measures of speech audibility in children ages 5 to 16 years old with congenital sensorineural hearing loss, who are capable of reliably indicating hearing sounds. Specifically, the project will use speech-elicited, envelope-following responses—a type of scalp-recorded measure that reflects neural activity to periodicity in speech. Study findings will reveal the accuracy of the chosen neural measure in confirming whether speech sounds are audible in children with congenital hearing loss when hearing aids are used. Results will inform future investigations and the clinical feasibility of using neural measures to assess hearing aid benefit in infants with hearing loss who are unable to confirm their detection of speech behaviorally.

Long-term goal: To use speech-elicited neural measures to quantify hearing aid benefit in infants soon after they are fit with hearing aids. The use of neural measures may enable confirmation of inadequate hearing aid benefit earlier than methods that rely on infants’ participation in hearing tests and, in turn, accelerate clinical decisions for improved access to speech.

Easwar is an audiologist who received clinical training in India and England and her doctorate in hearing science from Western University, Canada. She completed postdoctoral training in the Hospital for Sick Children, University of Toronto, and at the National Center for Audiology, Western University. She is now an investigator at the Waisman Center and a visiting assistant professor at the department of communication sciences and disorders, both at the University of Wisconsin–Madison.


One grant was awarded focused on research (e.g., animal models, brain imaging, biomarkers, electrophysiology) that will increase our understanding of the mechanisms, causes, diagnosis, and treatments of hyperacusis and severe forms of loudness intolerance. This grant was funded by Hyperacusis Research

erg 2019 Martinelli.jpg

+ David Martinelli, Ph.D.

University of Connecticut Health Center
Creation and validation of a novel, genetically induced animal model for hyperacusis

Hyperacusis is a condition in which a person experiences pain at much lower sound levels than listeners with typical hearing. While the presence of outer hair cell afferent neurons is known, it is not known what information the outer hair cells communicate to the brain through these afferents. This project’s hypothesis is that the function of these mysterious afferents is to communicate to the brain when sounds are intense enough to be painful and/or damaging, and that this circuitry is distinct from the cochlea-to-brain circuitry that provides general hearing. The hypothesis will be tested using a novel animal model in which a certain protein that is essential for the proposed “pain” circuit is missing. The absence of this protein is predicted to cause a lessening of the perception of auditory pain when high intensity sounds are presented. If true, this research has implications for those suffering from hyperacusis.

Long-term goal: To take advantage of the molecular mechanisms of the outer hair cell afferents and develop methods to dampen the perception of auditory pain, providing relief to those with hyperacusis without affecting traditional hearing.

Martinelli received his doctorate in developmental biology from Johns Hopkins University and the Carnegie Institution for Science and did postdoctoral training at Stanford University. He is an assistant professor of neuroscience at the University of Connecticut Health Center.


One grant was awarded for innovative research that will increase our understanding of the inner ear and balance disorder Ménière's disease. This grant was generously supported by a family committed to finding treatments and cures for Ménière's disease.


+ Ian Swinburne, Ph.D.

Harvard Medical School
Classifying the endolymphatic duct and sac cell types and their gene sets using high-throughput single-cell transcriptomics

To understand how the inner ear endolymphatic duct and sac stabilize the inner ear’s environment and to identify ways to restore or elevate this function to mitigate or cure Ménière's disease. The endolymphatic duct and sac play important roles in stabilizing a fluid composition necessary for sensing sound and balance. The recurrent vertigo in Ménière's is likely caused by a malfunction of the endolymphatic sac, causing volume or pressure changes in the inner ear.

Swinburne recently found that the typical-functioning endolymphatic sac periodically inflates and deflates like a balloon, and that specialized cell structures in the sac appear to transiently open, causing the deflation of the endolymphatic sac. The sac, then, appears to act as a relief valve to maintain a consistent volume and pressure within the inner ear. This project will generate a list of endolymphatic sac cell types and the genes governing their function, which will aid in Ménière's diagnosis (which can be delayed due to the range of fluctuating symptoms) and the development of a targeted drug or gene therapy.

Ian Swinburne received his Ph.D in Cell Biology from Harvard Medical School, where he studied gene regulation and the role of intron length on biological timing with Pamela Silver. He currently conducts research at Harvard Medical School on systems biology of the inner ear with Sean Megason. Notably, his imaging and genetic analyses revealed the mechanism by which the endolymphatic sac behaves like a relief valve to control inner ear pressure and volume. His goal is to identify the molecular basis of the relief valve physiology. Dr. Swinburne was also a 2013 Emerging Research Grants recipient. This project is a continuation of his 2018 grant.



The Les Paul Foundation Award for Tinnitus Research was awarded for research that will increase our understanding of the mechanisms, causes, diagnosis, and treatment of tinnitus.

erg19 Micheal Dent.jpg

+ Micheal Dent, Ph.D.

University at Buffalo, the State University of New York
Noise-induced tinnitus in mice

Animal models of tinnitus have employed many different behavioral techniques, only one of which is not subject to motivational issues and changes in auditory acuity. Tinnitus has previously been induced in rats following a sodium salicylate injection. In the present proposal, this paradigm will be modified to investigate tinnitus in mice. These experiments as a whole aim to determine the time course of tinnitus and its recovery following nontraumatic noise exposures in mice. Until there is an objective measure that separates hearing loss from tinnitus, it is difficult to use mice to study tinnitus. This project seeks to define a way to measure and characterize tinnitus in the awake and behaving mouse model in order to compare this to humans with tinnitus.

Long-term goal: To develop prevention and treatment strategies for tinnitus, a serious health condition affecting millions around the world.

Dent received her doctorate in psychology from the University of Maryland, College Park, and completed a postdoctoral fellowship in physiology at the University of Wisconsin Medical School. She is a psychology professor at the University at Buffalo.